Jamil Muradov is addressing the significant issue of concussions affecting over 42 million individuals annually, leading to long-term complications in some cases. His proposed solution involves using the clinically approved drug Memantine to inhibit abnormal brain activity triggered by concussions, showing promise in pre-clinical trials for potential use in human clinical trials and preventive sports concussion treatment.

Further Activities to have a look at